Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.6c00356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Zhisheng Jie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities and GDMPA Key Laboratory for Quality Control and Eva…. Hauptthemen laut MEDLINE: Glypicans, Fluorine Radioisotopes, Radiopharmaceuticals, Fluorides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Basic and Applied Basic Research Foundation of Guangdong Province, Southern Medical University.
Abstract (Originalsprache)
To develop an effective GPC3-targeted PET probe for tumor imaging, [18F]AlF-NOTA-A2P-GPC3P was synthesized by introducing the hydrophilic linker A2P into the L5 peptide scaffold. The probe was efficiently radiolabeled using the [18F]AlF method, exhibiting high hydrophilicity (Log D = -3.11 ± 0.31) and excellent in vitro and in vivo stability. Cellular uptake assays verified that the probe was significantly more highly taken up by GPC3-positive cell lines than by GPC3-low cell lines, confirming its specific binding to GPC3-positive cells. Micro-PET/CT and biodistribution studies in GPC3-positive tumor models (ASPC1, A549-GPC3) demonstrated specific uptake, significantly improved tumor-to-background ratios (especially tumor-to-lung and tumor-to-heart ratios), and reduced hepatic accumulation compared with the reported probe. Blocking studies in GPC3-positive tumors (ASPC1) confirmed its specificity. Thus, [18F]AlF-NOTA-A2P-GPC3P is a promising PET imaging agent for GPC3-positive tumor detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory Project of Guangdong Provincial Department of Education for Ordinary Universities and GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Department of Nuclear Medicine, Nanfa…
- School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong Province 510515, China.
ORCID-Profile: Jiawen Huang, Ganghua Tang
Förderung
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Southern Medical University
- Department of Education of Guangdong Province
- Guangzhou Municipal Science and Technology Project
- National Natural Science Foundation of China
- Guangdong Medical Products Administration
Zitieren
APA
Jie, Z., Tudi, K., Chen, Z., Huang, J., & Tang, G. (2026). Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c00356
Vancouver
Jie Z, Tudi K, Chen Z, Huang J, Tang G. Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.6c00356
BibTeX
@article{Jie2026,
author = {Jie, Zhisheng and Tudi, Kadeer and Chen, Zihao and Huang, Jiawen and Tang, Ganghua},
title = {Synthesis and Preclinical Evaluation of [ 18 F]AlF-NOTA-A2P-GPC3P for Imaging of GPC3},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.6c00356}
}
EUVIMED